Tau PET and Braak stage: highly predictive markers of cognitive decline that may allow prognostication of patient-specific progression risk

Abstract

Background: To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic markers of future cognitive decline in older adults with and without cognitive impairment.